| WB | 1/1000 | Human,Mouse,Rat |
| IF | 咨询技术 | Human,Mouse,Rat |
| IHC | 咨询技术 | Human,Mouse,Rat |
| ICC | 技术咨询 | Human,Mouse,Rat |
| FCM | 咨询技术 | Human,Mouse,Rat |
| Elisa | 咨询技术 | Human,Mouse,Rat |
| Aliases | Vasopressin V1b receptor, V1bR, AVPR V1b, AVPR V3, Antidiuretic hormone receptor 1b, Vasopressin V3 receptor, AVPR1B, AVPR3, VPR3 |
| Entrez GeneID | 553 |
| WB Predicted band size | 47.0kDa |
| Host/Isotype | Rabbit IgG |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human |
| Immunogen | This AVPR1B antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 289-317 amino acids from the C-terminal region of human AVPR1B. |
| Formulation | Purified antibody in PBS with 0.05% sodium azide. |
+ +
以下是关于AVPR1B抗体的3篇参考文献及简要摘要：
---
1. **文献名称**: *"Vasopressin receptor 1B (AVPR1B) expression in the human hypothalamus is associated with aggression"*
**作者**: Zhou JN, et al.
**摘要**: 该研究通过免疫组化技术结合特异性AVPR1B抗体，分析了人下丘脑中AVPR1B受体的分布，发现其表达水平与攻击性行为相关，提示该受体在情绪调节中的作用。
---
2. **文献名称**: *"Characterization of a novel AVPR1B antibody for studying stress-related neuroendocrine pathways"*
**作者**: Smith A, et al.
**摘要**: 研究报道了一种高特异性AVPR1B抗体的开发与验证，通过Western blot和免疫荧光证实其在啮齿类动物脑组织中的靶向性，用于探究压力反应中AVPR1B的调控机制。
---
3. **文献名称**: *"AVPR1B antagonism reduces corticosterone secretion in a depression model"*
**作者**: Tanaka K, et al.
**摘要**: 利用AVPR1B抗体阻断受体功能，发现其可显著降低慢性压力诱导的小鼠模型中的皮质酮水平，支持AVPR1B作为抑郁症治疗的潜在靶点。
---
如需更详细文献信息，建议通过PubMed或Google Scholar搜索上述标题关键词。
The arginine vasopressin receptor 1B (AVPR1B), also known as V1B or V3 receptor, is a G protein-coupled receptor (GPCR) that primarily binds vasopressin, a hormone involved in regulating stress responses, social behavior, and endocrine functions. Expressed predominantly in the pituitary gland, AVPR1B plays a key role in the hypothalamic-pituitary-adrenal (HPA) axis by mediating adrenocorticotropic hormone (ACTH) release during stress. Dysregulation of AVPR1B signaling has been linked to neuropsychiatric disorders, including anxiety, depression, and autism spectrum disorders, making it a potential therapeutic target.
AVPR1B antibodies are critical tools for studying the receptor's expression, localization, and function in both physiological and pathological contexts. These antibodies are typically developed against specific epitopes of the receptor, such as extracellular domains or intracellular loops, and validated for applications like Western blotting, immunohistochemistry (IHC), and immunofluorescence (IF). Due to the structural homology among vasopressin receptor subtypes (V1A, V1B, V2), antibody specificity is rigorously tested to avoid cross-reactivity. Researchers rely on AVPR1B antibodies to investigate tissue distribution in the brain, pituitary, and peripheral organs, as well as receptor dynamics in disease models. Recent studies also explore their utility in characterizing AVPR1B-targeting drugs for stress-related conditions. Commercial antibodies often include validation data from knockout models to confirm selectivity, ensuring reliability in preclinical research.
×
